FDA Approved Medical Products for:

Congenital antithrombin deficiency type 3

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Antithrombin III (human)
Trade Name
(Manufacturer Name)
ATnativ
(Pharmacia & Upjohn AB)
Indication
The FDA has approved this product to be used in this manner.
For the treatment of patients with hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism.
More Information about this product Drug Information Portal

Generic Name Recombinant human antithrombin
Trade Name
(Manufacturer Name)
Atryn®
(GTC Biotherapeutics, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.
More Information about this product Drug Information Portal

Generic Name Antithrombin III (human)
Trade Name
(Manufacturer Name)
Thrombate III®
(Talecris Biotherapeutics)
Indication
The FDA has approved this product to be used in this manner.
For replacement therapy in congenital deficiency of AT-III for prevention and treatment of thrombosis and pulmonary emboli.
More Information about this product Drug Information Portal